Sunbelt Securities’s Akebia Therapeutics AKBA Stock Holding History

Sunbelt Securities’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47	Buy	+34	New	+$47	﹤0.01%	2775
2025 Q4	–	Sell	-83	Closed	-$227	–	2786
2025 Q3	$227	Buy	+83	New	+$276	﹤0.01%	2394
2023 Q2	–	Sell	-14,000	Closed	-$7.88K	–	1694
2023 Q1	$7.88K	Hold	14,000	–	–	﹤0.01%	1196
2022 Q4	$8.08K	Hold	14,000	–	–	﹤0.01%	452
2022 Q3	$4K	Hold	14,000	–	–	﹤0.01%	427
2022 Q2	$5K	Buy	14,000 +2,450	+21%	+$1.03K	﹤0.01%	436
2022 Q1	$10K	Hold	11,550	–	–	﹤0.01%	450
2021 Q4	$21K	Buy	+11,550	New	+$31.5K	﹤0.01%	462
2021 Q2	–	Sell	-39,610	Closed	-$134K	–	441
2021 Q1	$134K	Buy	+39,610	New	+$143K	0.03%	407

Other funds holding AKBA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sunbelt Securities's AKBA Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Akebia Therapeutics (AKBA) in Q1 2026: 34 shares worth $47. The stake represents ﹤0.01% of the portfolio and ranks #2775 among its holdings. This is a return to the name: Sunbelt Securities previously reported a position in AKBA as recently as Q3 2025.

Sunbelt Securities first reported a position in AKBA in Q1 2021 and has held it in 9 quarters since. The position peaked at $134K in Q1 2021. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

Sunbelt Securities held 34 shares of Akebia Therapeutics worth $47 as of Q1 2026.
Akebia Therapeutics was a new Sunbelt Securities position in Q1 2026.
Akebia Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2775 holding.
Sunbelt Securities first reported a position in Akebia Therapeutics in Q1 2021 and has held it in 9 quarters since.
Sunbelt Securities's Akebia Therapeutics position peaked at $134K in Q1 2021.
171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.